Clinical Trials Directory

Trials / Completed

CompletedNCT07053930

Comparison of the Mean Duration of 3rd Stage of Labour Between Intraumbilical and Intravenous Oxytocin

To Compare the Mean Duration of Third Stage of Labour Between Intraumbilical and Intravenous Oxytocin.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
RESnTEC, Institute of Research · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

There is always a debate for choosing the best method for management of the third stage of labour (TSL) in the general practice for reducing the duration of TSL. Although intravenous oxytocin is more extensively used in general practice for managing TSL than intraumbilical, it still needs to be properly investigated among local populations and in local settings.

Detailed description

The findings of this study could identify the better route of oxytocin injection that could guide clinicians and health providers to opt for the better route in their routine practice for the management of TSL in order to reduce the morbidity and mortality of the patients, especially for developing countries like Pakistan, where most of the deliveries are conducted at peripheral or rural centers by a nurse, midwife, or a trained dai.

Conditions

Interventions

TypeNameDescription
DRUGIntraumbilical oxytocinPatients were given 10 U of intraumbilical oxytocin, diluted in 10 mL of normal saline.
DRUGIntravenous oxytocinPatients received 20 U of intravenous oxytocin diluted in 500 mL of normal saline.

Timeline

Start date
2024-10-01
Primary completion
2025-03-31
Completion
2025-03-31
First posted
2025-07-08
Last updated
2025-07-08

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07053930. Inclusion in this directory is not an endorsement.